These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6814877)

  • 21. The role of enzymes of the arterial wall in the pathogenesis of atherosclerosis.
    Mrhová O; Urbanová D
    Czech Med; 1983; 6(1):58-9. PubMed ID: 6409559
    [No Abstract]   [Full Text] [Related]  

  • 22. Modification of enzyme activities in experimental atherosclerosis in the rabbit.
    Patelski J; Bowyer DE; Howard AN; Jennings IW; Thorne CJ
    Atherosclerosis; 1970; 12(1):41-53. PubMed ID: 5476252
    [No Abstract]   [Full Text] [Related]  

  • 23. Lack of effect of phenformin, pyridinolcarbamate combined with a decalcifying agent, and an onion--garlic mixture on growth and necrosis of aortic atherosclerosis in ballooned swine.
    Lee WM; Lee KT
    Exp Mol Pathol; 1980 Dec; 33(3):345-8. PubMed ID: 6450054
    [No Abstract]   [Full Text] [Related]  

  • 24. Biopharmaceutical studies on pyridinolcarbamate. V. Effect of repeated administration of pyridinolcarbamate on the renal excretion of sulbenicillin in rabbits.
    Suenaga A; Nakagawa H; Huang MT; Imamura Y; Otagiri M; Ichibagase H
    Acta Pharm Suec; 1985; 22(1):45-52. PubMed ID: 4024967
    [No Abstract]   [Full Text] [Related]  

  • 25. Aortic lathyrism: ultrastructural study of lesions in the aortic wall and the protective effect of pyridinol carbamate.
    Pieraggi MT; Julian M; Bouissou H
    Gerontologia; 1974; 20(4):193-211. PubMed ID: 4463145
    [No Abstract]   [Full Text] [Related]  

  • 26. Activity of selected enzymes in arterial wall and blood serum of rats with experimental atherosclerosis.
    Olczyk K; Drŏzdz M; Piwowarczyk B
    Acta Biol Med Ger; 1981; 40(6):831-5. PubMed ID: 6915690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the mechanism of antiatherosclerotic agents: microchemical studies on the in vitro effects of pyridinol carbamate and estrogen (premarin) on phosphofructokinase and malate dehydrogenase in the arterial wall.
    Numano F; Yamasawa S; Takano T; Shimamoto T
    Mech Ageing Dev; 1973; 2(1):43-53. PubMed ID: 4352474
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of repeated administration of pyridinolcarbamate on hypoglycemic activity after oral administration of acetohexamide in rabbits.
    Suenaga A
    Pharm Acta Helv; 1986; 61(4):125-8. PubMed ID: 3725809
    [No Abstract]   [Full Text] [Related]  

  • 29. Antiatherogenic effect of pyridinolcarbamate (prodectin). Experimental study.
    Orbetzova V; Jurukova Z; Orbetzova M
    Artery; 1980; 8(6):560-9. PubMed ID: 7259535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histochemistry of atherosclerosis.
    Adams CW
    Sci Basis Med Annu Rev; 1969; ():19-43. PubMed ID: 4917835
    [No Abstract]   [Full Text] [Related]  

  • 31. [Anti-atherosclerotic and antihypertensive agents (XI)].
    Eguchi Y; Sugimoto A; Ito S; Nakajima M; Kaneko S; Ishikawa M
    Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1984; 18():17-23. PubMed ID: 6598493
    [No Abstract]   [Full Text] [Related]  

  • 32. Histoenzymology of muscular arterioles.
    Bordeianu A; Baltă N; Ciplea AL; Saptefraţi V
    Physiologie; 1976; 13(1):73-4. PubMed ID: 817350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental study on atherosclerosis--an attempt at its prevention and treatment.
    Shimamoto T
    Acta Pathol Jpn; 1969 Feb; 19(1):15-43. PubMed ID: 4309352
    [No Abstract]   [Full Text] [Related]  

  • 34. Interaction between salicylic acid and repeatedly administered pyridinolcarbamate in rabbits.
    Suenaga A; Kinoshita Y; Imamura Y; Otagiri M; Ichibagase H
    Pharm Acta Helv; 1987; 62(8):221-5. PubMed ID: 3659058
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experimental animal studies on the anti-inflammatory effect of pyridinolcarbamate].
    Rave O; Wagner H; Hrubesch M; Junge-Hülsing G; Hauss WH
    Arzneimittelforschung; 1974 Nov; 24(11):1779-85. PubMed ID: 4280911
    [No Abstract]   [Full Text] [Related]  

  • 36. Preparation and evaluation of the antiatherosclerotic activity of unsymmetrical pyridinolcarbamates.
    Ito S; Kobayashi M; Ishikawa M
    Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1989; 23():49-58. PubMed ID: 2488963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Structure-activity features of malate dehydrogenase from human myocardium in atherosclerosis].
    Gil'miiarova FN; Radomskaia VM; Vinogradova LN; Kretova IG; Samykina LN
    Vopr Med Khim; 1993; 39(5):17-8. PubMed ID: 8279132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of pyridinolcarbamate on the skin microcirculation in patients with severe skin necroses. A double-blind trial study].
    Fagrell B
    Vasa; 1976; 5(4):366-72. PubMed ID: 1007546
    [No Abstract]   [Full Text] [Related]  

  • 39. Hyperreactive arterial endothelial cells in atherogenesis and cyclic AMP phosphodiesterase inhibitor in prevention and treatment of atherosclerotic disorders.
    Shimamoto T
    Jpn Heart J; 1975 Jan; 16(1):76-97. PubMed ID: 234547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long term lathyrism and atherogenic diet in the rat. Protective action of pyridinol carbamate.
    Pieraggi MT; De Graeve J; Julian M; Thiers JC; Bouissou H
    Virchows Arch A Pathol Anat Histol; 1980; 387(1):59-66. PubMed ID: 7467116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.